Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Tessa Therapeutics Names Biopharma Veteran Jeffrey H. Buchalter to Board of Directors 2019-03-01 07:15
MED-EL Study Shows That a Quarter of Adults Have Never Had Their Hearing Checked 2019-03-01 00:45
Ping An Good Doctor Announces Its 2018 Annual Results 2019-02-28 21:44
Trianni, Inc. Announces Issuance of Patent in Japan 2019-02-28 21:00
Envirotainer Opens RAP e2 Station in Shanghai 2019-02-28 16:28
WuXi Biologics Congratulates Amicus on Receiving FDA Breakthrough Therapy Designation for AT-GAA 2019-02-28 09:52
First Patient Dosed in a Clinical Trial of Tyvyt® (Sintilimab injection) in Combination with IBI305 as First Line Treatment for Patients with Advanced Hepatocellular Carcinoma 2019-02-28 08:30
INC: Cashews May Have Fewer Calories Than Previously Thought - New Scientific Findings 2019-02-27 21:11
Ping An Good Doctor's Revenue Up by 78.7% Y-o-Y in 2018 2019-02-27 20:44
Innovent Receives IFR Asia-Pacific IPO of the Year 2018 and IFR Asia Review Hong Kong Equity Issue of the Year 2018 Awards 2019-02-27 12:00
CStone Pharmaceuticals listed on the Hong Kong Stock Exchange today 2019-02-27 10:47
Blackford Analysis Commended by Frost & Sullivan for its Visionary Implementation of Platform-based Approaches in the Medical Imaging Space 2019-02-26 22:00
Cachet Asset Management to Lead the Latest Round of Funding for ProTom International Holding Company 2019-02-26 19:22
Focusing on Advanced Laboratory Instruments and Equipment, Building an All-around Live-action Space -- 2019 InnoLAB Salon Formally Kicked Off 2019-02-26 15:00
ABL Bio Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Novel Immune Check Point Bispecifics for $220 Million 2019-02-26 08:23
Gracell Biotechnologies Completes $85 Million Series B for Immune Cell Gene Therapies 2019-02-26 08:07
Gracell Biotechnologies Completes $85 Million Series B for Immune Cell Gene Therapies 2019-02-26 08:07
Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2019 2019-02-26 05:16
Top 3 Growth Opportunities for Digital Pathology-enabling Technology Companies 2019-02-26 03:13
Mallinckrodt Announces Extracorporeal Photopheresis (ECP) Research Collaboration Agreement With Transimmune AG 2019-02-25 22:00
1 942 943 944 945 946 1634